No Data
No Data
Evome Medical Technologies Announces Securities Issuances
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) announces it has received conditional approval from the TSX Venture Exchange (the
Evome Medical Technologies Announces Update Call With CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) today provided details on preliminary estimated revenues and margins from April an
Evome Medical Technologies Provides Biodex Operations Update
Evome Medical Technologies (EVMT.V) on Thursday provided an update on its turn-around plan, saying it has grown revenue at its core business unit, Biodex Medical Systems, while reducing total debt sig
Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt Is Cancelled
NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the "Company" or "Evome") highlighted the strengthening credit relationship with Pathward, N.A. ("Pathward"), the Company
Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) has reached an agreement with EB Sports Corp. (the "Buyer"), the parent company
Evome Medical Technologies Punctuates Turn Around Plan With Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") announced today preliminary annual financial results for the year ending December 31, 2023. Be